Body Mass Index (BMI) Chart for Evaluation of New Onset Diabetes while taking Lipitor, Crestor, or other Statins

In January of 2012, a study published in the medical journal Archives of Internal Medicine found that female patients between the ages of 50 and 79 who took statin medications (i.e., Lipitor and other LDL-lowering drugs) were 48 percent more likely to develop type 2 diabetes as compared to women in the same age group who did not take the drugs.  This study noted that “significantly increased risk of DM associated with statin use was observed among women with BMI lower than 25.0 when compared with women with BMI of 30.0 or higher after adjusting for all potential confounders.” The study also reported a significantly increased risk of DM with women with a BMI below 30 as compared to women above 30.

Being overweight is strongly linked to the development of type 2 diabetes and for this reason the findings of increased DM in patients with a BMI under 30 is especially significant, because people with a BMI under 30 generally do not have other risk factors for the development of the disease.

We are currently investigating these cases for a number of women.  The Brandi Law Firm is nationally recognized for its long involvement in cases involving defects in drugs or devices.  If you or a loved one have taken Lipitor and been diagnosed with Type II Diabetes, based on medical studies, there is a potential claim against the manufacturer.  If you would like more information, please contact the Brandi Law Firm by e-mail, visit or call 415-989-1800 or (800) 481-1615.